Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 230 results for "avandia"

Baron and Budd Announces $177 Million Settlement for Seven States Against Avandia Manufacturer GlaxoSmithKline
TVNewsCheck

GLAXOSMITHKLINE : Baron and Budd Reaches Settlement for Case A...

The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky , Maryland , Mississippi , New Mexico , South Carolina , Utah and West Virginia regarding the deceptive ... 4 Traders, 1 month ago
[x]  

9 images for avandia

TMC Net, 1 month ago
I Stock Analyst, 1 month ago
CNBC, 1 month ago
Fort Mills Times, 1 month ago
Fox 2 Now, 3 months ago
CNN, 4 months ago
Charles Ayoub, 4 months ago
CNBC, 5 months ago
JD Journal, 6 months ago
diaTribe

What Do We Want Out of Our Diabetes Treatments?

We want our diabetes treatments to be effective, but we also want them to be safe, and it is up to the FDA to decide if the benefits of a given medication outweigh the risks. Consider insulin: if misused, it can kill you, but its benefits it keeps ...
 diaTribe1 week ago

Safety profile of blockbuster blood thinner comes under question

The BMJ probe also suggests that there may be safety benefits to monitoring Pradaxa's anticoagulant effect on individual patients -- a practice deemed unnecessary by the Food and Drug Administration when it approved the medication's marketing four ...
 Los Angeles Times1 week ago

5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise

Summary 5 Big Pharma companies not previously covered here have track records in the diabetes care niche that make them worthy of consideration as partners in marketing Afrezza. However, in all but one case, Afrezza may compete with their ...
 Seeking Alpha1 week ago

Attorney Bryan Schefman Wins in US Court of Appeals July 16, 2014: Bloomfield Hills, Michigan, United States Court of Appeals for the 6th Circuit

Attorney Bryan Schefman argued successfully for the right of medical providers to seek charges and double damages under the Medicare Secondary Payor (MSP) act where a no-fault insurer has denied PIP benefits to a Medicare eligible insured. The Court ...
 PRWeb2 weeks ago

Lawsuit Settlement News Reports Bad Pharmaceutical Drug Cases Are Ongoing While Funding For Cash Advances and Free Attorney Legal Consultations Are Available

/PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company, which operates lawsuitsettlementnews.com announced today a primary focus on assisting plaintiffs of bad pharmaceutical drugs such as AndgroGel: Testosterone Creams, ...
 RCL Advisors2 weeks ago
[x]  

Database provides fresh evidence of effect of diabetes drugs on Alzheimer's

While clinical trials remain the gold standard for proving safety and efficacy, the scale, real-world mix of patients and relatively low costs associated with database-powered studies make them a useful option for researchers. This week a German ...
 Fierce Biotech IT2 weeks ago

U.K. gov names ex-biotech VC as life sci chief, Genfit's stock jumps, Woodford backs biotechs

Welcome to the latest edition of our weekly EuroBiotech Report . This week the United Kingdom government underlined the importance it places on life sciences--and the jobs it brings--by creating a position dedicated to the industry. George Freeman, ...
 FierceBiotech2 weeks ago

Diabetes Drug Shows Slight Effect on Dementia in German Study

July 14 (Bloomberg) -- Older Germans who took Takeda Pharmaceutical Co.'s diabetes medicine Actos were slightly less likely to develop dementia, according to a study that may do little to resolve questions about the drug's usefulness. The German ...
 Washington Post2 weeks ago
[x]  

FDA Once Again Reaches Conclusions At Odds With Its Own Staff

Once again the FDA has reached a conclusion that is directly opposed by some of its own scientists.Last month the FDA affirmed the safety of olmesartan, a popular blood pressure lowering drug (sold as Benicar and other names). But that reassuring ...
 Forbes.com2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less